Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
https://dxm-atlas.org/en/interactions/diphenhydramine-dimenhydrinate-doxylamine/
CompareKey points for this combination
Drowsiness, reduced alertness and anticholinergic effects. CYP2D6 inhibition is better supported for diphenhydramine. This means reduced activity of the enzyme. The supporting findings come from laboratory work and human interactions involving other substances; they do not allow the effect on DXM to be calculated [18].
General concepts in this text
Enzyme
A protein that helps chemical transformations in cells.
A transformation can build or break down a substance.
Sources: Enzyme
- OpenStax: General Neurochemistry Principles · Introduction to Behavioral Neuroscience, published 2024-11-13
CYP2D6
One of the CYP enzymes involved in processing drugs.
Inhibition means reducing enzyme activity; it can change the processing of drugs.
Sources: CYP2D6
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
Antimuscarinic action
Blocking the action of acetylcholine at muscarinic receptors.
Muscarinic receptors are one type of receptor for acetylcholine, a chemical messenger.
Sources: Antimuscarinic action
- IUPHAR PEP: The Parasympathetic Nervous System · Live institutional page read 2026-10-13; separate revision label unavailable
How well is this understood?
Mechanism confidence: high
Confidence in the mechanism: high
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: low
Confidence in direct human evidence involving DXM: low
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
Can the amount reaching the body change?
ⓘ
CYP2D6
One of the CYP enzymes involved in processing drugs.
Inhibition means reducing enzyme activity; it can change the processing of drugs.
Sources: CYP2D6
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
How can the effects add up?
ⓘ
Antimuscarinic effects, including impaired sweating and peripheral toxicity
ⓘ
Additive sedation, impaired consciousness or protective reflexes, and possible respiratory consequences
Sources
Check the review’s wording
Sedation and anticholinergic effects; CYP2D6 contribution better supported for diphenhydramine [18]
- [18] Significant interaction between the nonprescription antihistamine diphenhydramine and the CYP2D6 substrate metoprolol in healthy men with high or low CYP2D6 activity · Open publication
Antihistamines: context from the review
Diphenhydramine’s CYP2D6 inhibition is supported by in vitro findings and human interactions involving other substrates; the effect on DXM cannot be calculated from those observations. Other sedating antihistamines need not share the same CYP effect to create hazards [18]. Historical warnings about terfenadine cannot be transferred to all modern nonsedating antihistamines.